NEST First Japan Distributor Conference Successfully Concluded-무석내사생명과학기술주식유한회사

On April 15, 2026, NEST successfully held its first Japan Distributor Conference in Japan. The event marks an important milestone in NEST’s continued expansion and commitment to the Japanese market.

NEST Successfully Hosts First Japan Distributor Conference at InterContinental Tokyo Bay

On April 15, 2026, NEST successfully held its first Japan Distributor Conference at InterContinental Tokyo Bay. The event brought together 13 key distributors and 25 industry representatives from across Japan, marking NEST’s first structured channel meeting in the Japanese market. In the opening speech, Chairman Mr. Yang outlined NEST’s global development strategy and the strategic importance of Japan, providing clear direction and strengthening partner confidence.

1. Japan market

NEST has established a subsidiary in Tokyo and set up a local warehouse of approximately 100 m², forming a basic integrated operation system covering sales, storage, and service. Through continuous participation in local industry exhibitions and events, brand awareness in Japan continues to grow. Japan is widely recognized as a high-end benchmark market in life sciences and pharmaceutical packaging, with strong technological leadership and industry standards.

2. Strategic significance

NEST has achieved alignment across branding, strategy, and execution, evolving from a traditional distributor model to a long-term strategic partnership.

3. Global footprint

NEST products now cover North America, Europe, Southeast Asia, the Middle East, Japan, South Korea, and India. With a “global manufacturing + local warehousing + regional service” model, NEST continues to improve delivery efficiency and supply chain stability, transitioning toward a truly global operating system.

4. Corporate Strength: Dual-Driven by Manufacturing System and Quality Standards

NEST Life Sciences (Wuxi) Co., Ltd. was founded in 2009 and has been dedicated to life science and medical consumables, building a global high-end brand.

Manufacturing capabilities

The company operates a modern production base of approximately 27,000 m², including 10,600 m² Class 100,000 cleanroom, 3,600 m² Class 10,000 cleanroom, 2,300 m² injection pen controlled workshop, and 850 m² prefilled syringe molding area, enabling a fully integrated workflow from raw materials to final delivery.

Technology capabilities

NEST has introduced advanced ASB one-step injection stretch blow molding systems and Rhodotron TT300 electron beam sterilization equipment, ensuring high product quality and stable sterilization processes. Medical-grade raw materials compliant with USP Class VI are used under GMP standards.

Quality system

Certified with ISO 9001, ISO 13485, ISO 11137, FDA, CE, and other international standards, NEST fully implements GMP requirements to ensure global consistency and compliance.

Product portfolio and services

NEST offers a comprehensive range covering lab consumables, medical devices, pharmaceutical packaging, and biotech reagents, serving key fields such as drug development, vaccine production, cell therapy, and IVD.

Through continuous supply chain and process optimization, NEST shortens delivery cycles and improves customization capabilities, while building a global localized service network to provide end-to-end support from product selection to technical application and training.

With Japan as a strategic hub, NEST advances toward a higher level of global expansion

The successful launch of NEST’s first Japan Distributor Conference marks a key milestone in its globalization journey and signals a more mature phase of overseas development.

Against the backdrop of continuous advancement in the global life sciences industry, NEST is steadily transitioning from “Made in China” to a truly global brand.

반환목록

이전：NEST Tube is adopted by WHO, Uganda to test Ebola Vaccines in outbreak 2022-11-24

다음：Prefilled Automatic Pen Injectors: NEST's Manufacturing Edge 2026-07-20